APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain Disease Device and Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brain Disease Device and Software Industry Growth and Trends Forecast to 2032

1 January 2026112 pages

Choose your research edition.

Industry ResearchBrain Disease Device and Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain Disease Device and Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Brain Disease Device and Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain Disease Device and Software Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain Disease Device and Software Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Brain Disease Device and Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Brain Disease Device and Software market include United Imaging Healthcare Co., Ltd, Koninklijke Philips N.V., GE, Canon, Inc, Siemens Healthineers AG, Vuno Co., Ltd, Fujifilm Holdings Corporation, Aspect Imaging and IXICO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brain Disease Device and Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brain Disease Device and Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brain Disease Device and Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brain Disease Device and Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Brain Disease Device and Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brain Disease Device and Software Market by Company

United Imaging Healthcare Co., Ltd

Koninklijke Philips N.V.

GE

Canon, Inc

Siemens Healthineers AG

Vuno Co., Ltd

Fujifilm Holdings Corporation

Aspect Imaging

IXICO

QMENTA

Cortechs.ai

Quantib

Brainomix

Qure.AI

Imaging Biometrics, LLC

A.I. Analysis, Inc

Brain Disease Device and Software Segment by Type

Brain Disease Device

Brain Disease Software

Brain Disease Device and Software Segment by Application

Hospitals and Clinics

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Brain Disease Device and Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Disease Device and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain Disease Device and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Disease Device and Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Brain Disease Device and Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Brain Disease Device and Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Brain Disease Device and Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Brain Disease Device and Software Market Share by Region (2021-2026) Table 4. Global Brain Disease Device and Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Brain Disease Device and Software Market Share by Region (2027-2032) Table 6. Global Brain Disease Device and Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Brain Disease Device and Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Brain Disease Device and Software Market Size Share by Type (2021-2026) Table 9. Global Brain Disease Device and Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Brain Disease Device and Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Brain Disease Device and Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Brain Disease Device and Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Brain Disease Device and Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Brain Disease Device and Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Brain Disease Device and Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Brain Disease Device and Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Brain Disease Device and Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Brain Disease Device and Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Brain Disease Device and Software Market Size Share by Application (2021-2026) Table 24. Global Brain Disease Device and Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Brain Disease Device and Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Brain Disease Device and Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Brain Disease Device and Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Brain Disease Device and Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Brain Disease Device and Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Brain Disease Device and Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Brain Disease Device and Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Brain Disease Device and Software Industry Trends Table 37. Brain Disease Device and Software Industry Drivers Table 38. Brain Disease Device and Software Industry Opportunities and Challenges Table 39. Brain Disease Device and Software Industry Restraints Table 40. Global Brain Disease Device and Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Brain Disease Device and Software Revenue Market Share by Company (2021-2026) Table 42. Global Brain Disease Device and Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Brain Disease Device and Software Key Company Headquarters & Area Served Table 44. Global Brain Disease Device and Software Company, Product Type & Application Table 45. Global Brain Disease Device and Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Brain Disease Device and Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. United Imaging Healthcare Co., Ltd Company Information Table 49. United Imaging Healthcare Co., Ltd Business Overview Table 50. United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Portfolio Table 52. United Imaging Healthcare Co., Ltd Recent Development Table 53. Koninklijke Philips N.V. Company Information Table 54. Koninklijke Philips N.V. Business Overview Table 55. Koninklijke Philips N.V. Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Koninklijke Philips N.V. Brain Disease Device and Software Product Portfolio Table 57. Koninklijke Philips N.V. Recent Development Table 58. GE Company Information Table 59. GE Business Overview Table 60. GE Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GE Brain Disease Device and Software Product Portfolio Table 62. GE Recent Development Table 63. Canon, Inc Company Information Table 64. Canon, Inc Business Overview Table 65. Canon, Inc Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Canon, Inc Brain Disease Device and Software Product Portfolio Table 67. Canon, Inc Recent Development Table 68. Siemens Healthineers AG Company Information Table 69. Siemens Healthineers AG Business Overview Table 70. Siemens Healthineers AG Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Siemens Healthineers AG Brain Disease Device and Software Product Portfolio Table 72. Siemens Healthineers AG Recent Development Table 73. Vuno Co., Ltd Company Information Table 74. Vuno Co., Ltd Business Overview Table 75. Vuno Co., Ltd Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Vuno Co., Ltd Brain Disease Device and Software Product Portfolio Table 77. Vuno Co., Ltd Recent Development Table 78. Fujifilm Holdings Corporation Company Information Table 79. Fujifilm Holdings Corporation Business Overview Table 80. Fujifilm Holdings Corporation Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Fujifilm Holdings Corporation Brain Disease Device and Software Product Portfolio Table 82. Fujifilm Holdings Corporation Recent Development Table 83. Aspect Imaging Company Information Table 84. Aspect Imaging Business Overview Table 85. Aspect Imaging Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Aspect Imaging Brain Disease Device and Software Product Portfolio Table 87. Aspect Imaging Recent Development Table 88. IXICO Company Information Table 89. IXICO Business Overview Table 90. IXICO Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. IXICO Brain Disease Device and Software Product Portfolio Table 92. IXICO Recent Development Table 93. QMENTA Company Information Table 94. QMENTA Business Overview Table 95. QMENTA Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. QMENTA Brain Disease Device and Software Product Portfolio Table 97. QMENTA Recent Development Table 98. Cortechs.ai Company Information Table 99. Cortechs.ai Business Overview Table 100. Cortechs.ai Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cortechs.ai Brain Disease Device and Software Product Portfolio Table 102. Cortechs.ai Recent Development Table 103. Quantib Company Information Table 104. Quantib Business Overview Table 105. Quantib Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Quantib Brain Disease Device and Software Product Portfolio Table 107. Quantib Recent Development Table 108. Brainomix Company Information Table 109. Brainomix Business Overview Table 110. Brainomix Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Brainomix Brain Disease Device and Software Product Portfolio Table 112. Brainomix Recent Development Table 113. Qure.AI Company Information Table 114. Qure.AI Business Overview Table 115. Qure.AI Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Qure.AI Brain Disease Device and Software Product Portfolio Table 117. Qure.AI Recent Development Table 118. Imaging Biometrics, LLC Company Information Table 119. Imaging Biometrics, LLC Business Overview Table 120. Imaging Biometrics, LLC Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Imaging Biometrics, LLC Brain Disease Device and Software Product Portfolio Table 122. Imaging Biometrics, LLC Recent Development Table 123. A.I. Analysis, Inc Company Information Table 124. A.I. Analysis, Inc Business Overview Table 125. A.I. Analysis, Inc Brain Disease Device and Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. A.I. Analysis, Inc Brain Disease Device and Software Product Portfolio Table 127. A.I. Analysis, Inc Recent Development Table 128. North America Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Brain Disease Device and Software Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Brain Disease Device and Software Market Share by Country (2021-2026) Table 131. North America Brain Disease Device and Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Brain Disease Device and Software Market Share Forecast by Country (2027-2032) Table 133. Europe Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Brain Disease Device and Software Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Brain Disease Device and Software Market Share by Country (2021-2026) Table 136. Europe Brain Disease Device and Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Brain Disease Device and Software Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Brain Disease Device and Software Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Brain Disease Device and Software Market Share by Country (2021-2026) Table 141. Asia-Pacific Brain Disease Device and Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Brain Disease Device and Software Market Share Forecast by Country (2027-2032) Table 143. Latin America Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Brain Disease Device and Software Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Brain Disease Device and Software Market Share by Country (2021-2026) Table 146. Latin America Brain Disease Device and Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Brain Disease Device and Software Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Brain Disease Device and Software Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Brain Disease Device and Software Market Share by Country (2021-2026) Table 151. Middle East & Africa Brain Disease Device and Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Brain Disease Device and Software Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Brain Disease Device and Software Product Image Figure 3. Global Brain Disease Device and Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Brain Disease Device and Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Brain Disease Device and Software Market Share by Region: 2025 VS 2032 Figure 6. Global Brain Disease Device and Software Market Share by Region (2021-2032) Figure 7. North America Brain Disease Device and Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Brain Disease Device and Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Brain Disease Device and Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Brain Disease Device and Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Brain Disease Device and Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Brain Disease Device Image Figure 13. Global Brain Disease Device Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Brain Disease Software Image Figure 15. Global Brain Disease Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Brain Disease Device and Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Brain Disease Device and Software Market Share by Type 2025 VS 2032 Figure 18. North America Brain Disease Device and Software Market Size Share by Type (2021-2032) Figure 19. Europe Brain Disease Device and Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Brain Disease Device and Software Market Size Share by Type (2021-2032) Figure 21. Latin America Brain Disease Device and Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Brain Disease Device and Software Market Size Share by Type (2021-2032) Figure 23. Hospitals and Clinics Image Figure 24. Global Hospitals and Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Diagnostic Imaging Centers Image Figure 26. Global Diagnostic Imaging Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Ambulatory Surgical Centers Image Figure 28. Global Ambulatory Surgical Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Brain Disease Device and Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Brain Disease Device and Software Market Share by Application 2025 VS 2032 Figure 31. North America Brain Disease Device and Software Market Size Share by Application (2021-2032) Figure 32. Europe Brain Disease Device and Software Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Brain Disease Device and Software Market Size Share by Application (2021-2032) Figure 34. Latin America Brain Disease Device and Software Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Brain Disease Device and Software Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Brain Disease Device and Software Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Brain Disease Device and Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Brain Disease Device and Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Brain Disease Device and Software Market Share by Country (2021-2032) Figure 41. Europe Brain Disease Device and Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Brain Disease Device and Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Brain Disease Device and Software Market Share by Country (2021-2032) Figure 44. Asia-Pacific Brain Disease Device and Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Brain Disease Device and Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Brain Disease Device and Software Market Share by Country (2021-2032) Figure 47. Latin America Brain Disease Device and Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Brain Disease Device and Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Brain Disease Device and Software Market Share by Country (2021-2032) Figure 50. Middle East & Africa Brain Disease Device and Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Brain Disease Device and Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Brain Disease Device and Software Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Brain Disease Device
  • Brain Disease Software
Applications
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
Companies covered
  • United Imaging Healthcare Co., Ltd
  • Koninklijke Philips N.V.
  • GE
  • Canon, Inc
  • Siemens Healthineers AG
  • Vuno Co., Ltd
  • Fujifilm Holdings Corporation
  • Aspect Imaging
  • IXICO
  • QMENTA
  • Cortechs.ai
  • Quantib
  • Brainomix
  • Qure.AI
  • Imaging Biometrics, LLC
  • A.I. Analysis, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Brain Disease Device and Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Brain Disease Device and Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Brain Disease Device and Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Brain Disease Device and Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Brain Disease Device and Software Market Size (2021-2032)
  8. 1.5.1 North America Brain Disease Device and Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Brain Disease Device and Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Brain Disease Device and Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Brain Disease Device and Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Brain Disease Device and Software Market Size Growth Rate (2021-2032)
2 Brain Disease Device and Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Brain Disease Device
  3. 2.1.2 Brain Disease Software
  4. 2.2 Global Brain Disease Device and Software Market Size by Type
  5. 2.2.1 Global Brain Disease Device and Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Brain Disease Device and Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Brain Disease Device and Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Brain Disease Device and Software Market Size by Regions
  9. 2.3.1 North America Brain Disease Device and Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Brain Disease Device and Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Brain Disease Device and Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Type (2021-2026)
3 Brain Disease Device and Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals and Clinics
  3. 3.1.2 Diagnostic Imaging Centers
  4. 3.1.3 Ambulatory Surgical Centers
  5. 3.2 Global Brain Disease Device and Software Market Size by Application
  6. 3.2.1 Global Brain Disease Device and Software Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Brain Disease Device and Software Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Brain Disease Device and Software Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Brain Disease Device and Software Market Size by Regions
  10. 3.3.1 North America Brain Disease Device and Software Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Brain Disease Device and Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Brain Disease Device and Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Brain Disease Device and Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Brain Disease Device and Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Brain Disease Device and Software Industry Trends
  2. 4.2 Brain Disease Device and Software Industry Drivers
  3. 4.3 Brain Disease Device and Software Industry Opportunities and Challenges
  4. 4.4 Brain Disease Device and Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Brain Disease Device and Software Revenue (2021-2026)
  2. 5.2 Global Brain Disease Device and Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Brain Disease Device and Software Key Company Headquarters & Area Served
  4. 5.4 Global Brain Disease Device and Software Company, Product Type & Application
  5. 5.5 Global Brain Disease Device and Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Brain Disease Device and Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Brain Disease Device and Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Brain Disease Device and Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 United Imaging Healthcare Co., Ltd
  2. 6.1.1 United Imaging Healthcare Co., Ltd Company Information
  3. 6.1.2 United Imaging Healthcare Co., Ltd Business Overview
  4. 6.1.3 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Portfolio
  6. 6.1.5 United Imaging Healthcare Co., Ltd Recent Developments
  7. 6.2 Koninklijke Philips N.V.
  8. 6.2.1 Koninklijke Philips N.V. Company Information
  9. 6.2.2 Koninklijke Philips N.V. Business Overview
  10. 6.2.3 Koninklijke Philips N.V. Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Koninklijke Philips N.V. Brain Disease Device and Software Product Portfolio
  12. 6.2.5 Koninklijke Philips N.V. Recent Developments
  13. 6.3 GE
  14. 6.3.1 GE Company Information
  15. 6.3.2 GE Business Overview
  16. 6.3.3 GE Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GE Brain Disease Device and Software Product Portfolio
  18. 6.3.5 GE Recent Developments
  19. 6.4 Canon, Inc
  20. 6.4.1 Canon, Inc Company Information
  21. 6.4.2 Canon, Inc Business Overview
  22. 6.4.3 Canon, Inc Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Canon, Inc Brain Disease Device and Software Product Portfolio
  24. 6.4.5 Canon, Inc Recent Developments
  25. 6.5 Siemens Healthineers AG
  26. 6.5.1 Siemens Healthineers AG Company Information
  27. 6.5.2 Siemens Healthineers AG Business Overview
  28. 6.5.3 Siemens Healthineers AG Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Siemens Healthineers AG Brain Disease Device and Software Product Portfolio
  30. 6.5.5 Siemens Healthineers AG Recent Developments
  31. 6.6 Vuno Co., Ltd
  32. 6.6.1 Vuno Co., Ltd Company Information
  33. 6.6.2 Vuno Co., Ltd Business Overview
  34. 6.6.3 Vuno Co., Ltd Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Vuno Co., Ltd Brain Disease Device and Software Product Portfolio
  36. 6.6.5 Vuno Co., Ltd Recent Developments
  37. 6.7 Fujifilm Holdings Corporation
  38. 6.7.1 Fujifilm Holdings Corporation Company Information
  39. 6.7.2 Fujifilm Holdings Corporation Business Overview
  40. 6.7.3 Fujifilm Holdings Corporation Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Fujifilm Holdings Corporation Brain Disease Device and Software Product Portfolio
  42. 6.7.5 Fujifilm Holdings Corporation Recent Developments
  43. 6.8 Aspect Imaging
  44. 6.8.1 Aspect Imaging Company Information
  45. 6.8.2 Aspect Imaging Business Overview
  46. 6.8.3 Aspect Imaging Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Aspect Imaging Brain Disease Device and Software Product Portfolio
  48. 6.8.5 Aspect Imaging Recent Developments
  49. 6.9 IXICO
  50. 6.9.1 IXICO Company Information
  51. 6.9.2 IXICO Business Overview
  52. 6.9.3 IXICO Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 IXICO Brain Disease Device and Software Product Portfolio
  54. 6.9.5 IXICO Recent Developments
  55. 6.10 QMENTA
  56. 6.10.1 QMENTA Company Information
  57. 6.10.2 QMENTA Business Overview
  58. 6.10.3 QMENTA Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 QMENTA Brain Disease Device and Software Product Portfolio
  60. 6.10.5 QMENTA Recent Developments
  61. 6.11 Cortechs.ai
  62. 6.11.1 Cortechs.ai Company Information
  63. 6.11.2 Cortechs.ai Business Overview
  64. 6.11.3 Cortechs.ai Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cortechs.ai Brain Disease Device and Software Product Portfolio
  66. 6.11.5 Cortechs.ai Recent Developments
  67. 6.12 Quantib
  68. 6.12.1 Quantib Company Information
  69. 6.12.2 Quantib Business Overview
  70. 6.12.3 Quantib Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Quantib Brain Disease Device and Software Product Portfolio
  72. 6.12.5 Quantib Recent Developments
  73. 6.13 Brainomix
  74. 6.13.1 Brainomix Company Information
  75. 6.13.2 Brainomix Business Overview
  76. 6.13.3 Brainomix Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Brainomix Brain Disease Device and Software Product Portfolio
  78. 6.13.5 Brainomix Recent Developments
  79. 6.14 Qure.AI
  80. 6.14.1 Qure.AI Company Information
  81. 6.14.2 Qure.AI Business Overview
  82. 6.14.3 Qure.AI Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Qure.AI Brain Disease Device and Software Product Portfolio
  84. 6.14.5 Qure.AI Recent Developments
  85. 6.15 Imaging Biometrics, LLC
  86. 6.15.1 Imaging Biometrics, LLC Company Information
  87. 6.15.2 Imaging Biometrics, LLC Business Overview
  88. 6.15.3 Imaging Biometrics, LLC Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Imaging Biometrics, LLC Brain Disease Device and Software Product Portfolio
  90. 6.15.5 Imaging Biometrics, LLC Recent Developments
  91. 6.16 A.I. Analysis, Inc
  92. 6.16.1 A.I. Analysis, Inc Company Information
  93. 6.16.2 A.I. Analysis, Inc Business Overview
  94. 6.16.3 A.I. Analysis, Inc Brain Disease Device and Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 A.I. Analysis, Inc Brain Disease Device and Software Product Portfolio
  96. 6.16.5 A.I. Analysis, Inc Recent Developments
7 North America
  1. 7.1 North America Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Brain Disease Device and Software Market Size by Country (2021-2026)
  3. 7.3 North America Brain Disease Device and Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Brain Disease Device and Software Market Size by Country (2021-2026)
  3. 8.3 Europe Brain Disease Device and Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Brain Disease Device and Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Brain Disease Device and Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Brain Disease Device and Software Market Size by Country (2021-2026)
  3. 10.3 South America Brain Disease Device and Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Brain Disease Device and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Brain Disease Device and Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Brain Disease Device and Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst